Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPOD
5151
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $137K | ﹤0.01% |
+10,000
| New | +$124K |
|
5152
PAVmed
PAVM
$37.2M
| $136K | ﹤0.01% |
143
+100
| +233% | +$85.5K |
|
|
PZC
5153
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $136K | ﹤0.01% |
+13,237
| New | +$137K |
|
|
EVLO
5154
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $136K | ﹤0.01% |
561
+51
| +10% | +$6.31K |
|
|
SCVX.WS
5155
DELISTED
SCVX Corp.
SCVX.WS
| $136K | ﹤0.01% |
+80,000
| New | +$106K |
|
|
RSVAU
5156
DELISTED
Rodgers Silicon Valley Acquisition Corp. Unit
RSVAU
| $134K | ﹤0.01% |
+10,000
| New | +$122K |
|
5157
BBVA Argentina
BBAR
$3.61B
| $133K | ﹤0.01% |
41,571
-6,103
| -13% | -$18.1K |
|
|
FARM
5158
DELISTED
Farmer Brothers
FARM
| $133K | ﹤0.01% |
28,503
+5,273
| +23% | +$22.6K |
|
5159
PUT
Prothena Corp
PRTA
$437M
| $133K | ﹤0.01% |
11,100
-27,200
| -71% | -$322K |
|
|
FLNA
5160
Filana Therapeutics
FLNA
$45.7M
| $133K | ﹤0.01% |
19,448
+6,905
| +55% | +$61.6K |
|
5161
Uranium Energy
UEC
$5.33B
| $133K | ﹤0.01% |
76,087
+20,095
| +36% | +$23.7K |
|
|
SBT
5162
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $131K | ﹤0.01% |
28,867
-18,357
| -39% | -$71.2K |
|
5163
IGC Pharma
IGC
$25.8M
| $130K | ﹤0.01% |
83,260
+16,980
| +26% | +$25.1K |
|
5164
Energous
WATT
$98.4M
| $130K | ﹤0.01% |
120
-2
| -2% | -$2.64K |
|
|
AUTL
5165
Autolus Therapeutics
AUTL
$519M
| $129K | ﹤0.01% |
14,385
-13,189
| -48% | -$141K |
|
5166
Citizens
CIA
$231M
| $129K | ﹤0.01% |
22,600
+98
| +0.4% | +$589 |
|
5167
Limbach Holdings
LMB
$574M
| $129K | ﹤0.01% |
10,490
+129
| +1% | +$1.38K |
|
|
GHL
5168
DELISTED
Greenhill & Co., Inc.
GHL
| $129K | ﹤0.01% |
10,587
-18,052
| -63% | -$233K |
|
5169
Duluth Holdings
DLTH
$160M
| $128K | ﹤0.01% |
12,145
-156
| -1% | -$2.13K |
|
5170
Evolus
EOLS
$474M
| $128K | ﹤0.01% |
38,237
+3,924
| +11% | +$14.7K |
|
|
WTER
5171
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $128K | ﹤0.01% |
8,436
+5,328
| +171% | +$100K |
|
|
AIOT
5172
PowerFleet Inc
AIOT
$558M
| $127K | ﹤0.01% |
17,039
-83,748
| -83% | -$560K |
|
|
HEXO
5173
DELISTED
HEXO Corp. Common Shares
HEXO
| $127K | ﹤0.01% |
2,464
+265
| +12% | +$12.5K |
|
|
EHI
5174
Western Asset Global High Income Fund
EHI
$177M
| $126K | ﹤0.01% |
+12,594
| New | +$126K |
|
5175
GSI Technology
GSIT
$254M
| $126K | ﹤0.01% |
17,027
-1,593
| -9% | -$10.5K |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.